Back
Stoke Therapeutics Stock Price Chart

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
STOK
Stoke Therapeutics
Last Price:
$8.15
Seasonality Move:
19.76%
7 Day Trial
ALL ACCESS PASS
$
7

Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight buying pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.48 | Sell |
20-day SMA: | 8.24 | Sell |
50-day SMA: | 9.51 | Sell |
200-day SMA: | 12.47 | Sell |
8-day EMA: | 8.38 | Sell |
20-day EMA: | 8.62 | Sell |
50-day EMA: | 9.49 | Sell |
200-day EMA: | 11.01 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 42.44 | Sell |
Chaikin Money Flow: | 592896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.75 - 9.47) | Sell |
Bollinger Bands (100): | (9.1 - 12.66) | Sell |
Stoke Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 8.15 while STOK 8-day simple moving average is 8.48, which is a Sell signal.
-
The stock price of STOK is 8.15 while Stoke Therapeutics 20-day SMA is 8.24, which makes it a Sell.
-
Stoke Therapeutics 50-day simple moving average is 9.51 while STOK share price is 8.15, making it a Sell technically.
-
STOK stock price is 8.15 and Stoke Therapeutics 200-day simple moving average is 12.47, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
35
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $8.15. The Score for STOK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
440.7M
Price in USD:
8.15
Share Volume:
1.4M
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
5.80
Sell
35
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 8.15 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 8.15 while STOK 8-day exponential moving average is 8.38, which is a Sell signal.
-
The stock price of STOK is 8.15 while Stoke Therapeutics 20-day EMA is 8.62, which makes it a Sell.
-
Stoke Therapeutics 50-day exponential moving average is 9.49 while STOK share price is 8.15, making it a Sell technically.
-
STOK stock price is 8.15 and Stoke Therapeutics 200-day simple moving average is 11.01, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.83 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Stoke Therapeutics is a Sell
-
Stoke Therapeutics Relative Strength Index (RSI) is 42.44, which suggest Stoke Therapeutics is oversold
-
The Bollinger Bands (25) for Stoke Therapeutics is (7.75 - 9.47), which suggest Stoke Therapeutics is a Sell
-
The Bollinger Bands (100) for Stoke Therapeutics is (9.1 - 12.66), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.